The health-system specialty pharmacy has the unique ability to coordinate better with the provider and take a team approach that reduces the chances of dropping the ball on the patient’s care.
There are multiple levers that need to be pulled to allow biosimilars to come to market more broadly in the US, explained Fran Gregory, PharmD, MBA, vice president of emerging therapies, Cardinal Health.
The 2023 Asembia Specialty Pharmacy Summit took place in early May in Las Vegas, Nevada, and The American Journal of Managed Care® was there to cover the meeting catch up on what you may have missed.
Fran Gregory, PharmD, MBA, vice president of Emerging Therapies at Cardinal Health, discussed the role biosimilars are playing in the pharmaceutical market as well as in patient access.
With a growing expectation for individualized and personalized care, medically integrated pharmacies have a great opportunity to support patients and the care team.